#AIMOVIG CO PAY CARD FULL#

This offer is only valid in the United States, Puerto Rico, and the US territories. A patient is considered cash-paying where the patient has no insurance coverage for Aimovig or where the patient has commercial or private insurance but Amgen in its sole discretion determines the patient is effectively uninsured because such coverage does not provide a material level of financial assistance for the cost of an Aimovig prescription. It is not valid for cash-paying patients or where prohibited by law. This offer is not valid for patients whose Aimovig prescription is paid for in whole or in part by Medicare, Medicaid, or any other federal or state programs.

There is no income requirement to participate in this program. This program helps eligible patients cover out-of-pocket costs related to Aimovig, up to program limits. (See PROGRAM BENEFITS section below.)Įligibility Criteria: Subject to program limitations and terms and conditions, the Aimovig ®(erenumab-aooe) Copay Card is open to patients who have an Aimovig prescription and who have commercial or private insurance, including plans available through state and federal healthcare exchanges. Please ask your AimAlly ™ Support Team to help you understand eligibility for the Aimovig ® Copay Card, and whether your particular insurance coverage is likely to result in your reaching the Maximum Monthly Benefit, the Maximum Annual Program Benefit, or your Patient Total Program Benefit, by calling 1-833-AIMOVIG (1-83). Whether you are eligible to receive the Maximum Monthly Benefit, Maximum Program Benefit or Patient Total Program Benefit is determined by the type of plan coverage you have. If a patient's commercial insurance plan imposes different or additional requirements on patients who receive Aimovig ® Copay Card benefits, Amgen has the right to reduce or eliminate those benefits.

The Aimovig ® Copay Card provides support up to the Maximum Monthly Benefit, the Maximum Annual Program Benefit and/or Patient Total Program Benefit.

Offer is subject to change or discontinuation without notice.

The program provides assistance up to a Maximum Monthly Benefit except that the Maximum Monthly Benefit will not apply to the first 2 uses of the Aimovig ® Copay Card for Aimovig in any given calendar year.

Patients are responsible for all amounts that exceed these limits.

Amgen will pay the remaining eligible out-of-pocket costs on behalf of the patient up to a Maximum Monthly Benefit, a Maximum Annual Program Benefit and/or the Patient Total Program Benefit. Monthly out-of-pocket costs include co-payment, co-insurance, and deductible out-of-pocket costs. With the Aimovig ® Copay Card, a commercially insured patient who meets eligibility criteria may pay as little as a $5 copay per month for their Aimovig monthly out-of-pocket costs.The program is not valid for patients whose Aimovig prescription is paid for in whole or in part by Medicare, Medicaid, or any other federal or state programs. The Aimovig ® Copay Card is open to patients with commercial insurance, regardless of financial need.

The following summary is not a substitute for reviewing the Terms and Conditions in their entirety.

#AIMOVIG CO PAY CARD FULL#

It is important that every patient read and understand the full Aimovig ® (erenumab-aooe) Copay Card Terms and Conditions. Aimovig ® Copay Card Terms and Conditions

Aimovig co pay card